Progesterone Receptor Negative Active Not Recruiting Phase 3 Trials for Docetaxel (DB01248)

IndicationStatusPhase
DBCOND0038639 (Progesterone Receptor Negative)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01275677Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast CancerTreatment